Narcolepsy Drug Trends and Forecast
The future of the global narcolepsy drug market looks promising with opportunities in the central nervous system stimulants, tricyclic antidepressants, sodium oxybate, and selective serotonin reuptake inhibitor markets. The global narcolepsy drug market is expected to grow with a CAGR of 9.4% from 2024 to 2030. The major drivers for this market are increasing awareness towards narcolepsy and its symptoms among healthcare professionals and rising global prevalence of narcolepsy owing to increasing stress, peer pressure, and social & economic hardships.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Narcolepsy Drug by Segment
The study includes a forecast for the global narcolepsy drug by disease type, therapeutics type, and region.
Narcolepsy Drug Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:
• Daytime Extreme Sleepiness
• Cataplexia
• Others
• Central Nervous System Stimulants
• Tricyclic Antidepressants
• Sodium Oxybate
• Selective Serotonin Reuptake Inhibitor
• Others
Narcolepsy Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Narcolepsy Drug Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies narcolepsy drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the narcolepsy drug companies profiled in this report include-
• Arena Pharmaceuticals
• Bioprojet Company
• Graymark Healthcare
• Hikma Pharmaceuticals
• Jazz Pharmaceuticals
• Ligand Pharmaceuticals Incorporated
• Shionogi
Narcolepsy Drug Market Insights
Lucintel forecasts that daytime extreme sleepiness will remain the larger segment over the forecast period due to development of drugs for treating narcolepsy.
Within this market, sodium oxybate will remain the largest segment due to extensive utilization in the narcolepsy treatment.
North America is expected to witness highest growth over the forecast period due to growing prevalence of unhealthy lifestyles along with increase in R&D activities in the region.
Features of the Global Narcolepsy Drug Market
Market Size Estimates: Narcolepsy drug market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Narcolepsy drug market size by disease type, therapeutics type, and region in terms of value ($B).
Regional Analysis: Narcolepsy drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different disease types, therapeutics types, and regions for the narcolepsy drug market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the narcolepsy drug market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for narcolepsy drug market?
Answer: The global narcolepsy drug market is expected to grow with a CAGR of 9.4% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the narcolepsy drug market?
Answer: The major drivers for this market are increasing awareness towards narcolepsy and its symptoms among healthcare professionals and rising global prevalence of narcolepsy owing to increasing stress, peer pressure, and social & economic hardships.
Q3. What are the major segments for narcolepsy drug market?
Answer: The future of the narcolepsy drug market looks promising with opportunities in the central nervous system stimulants, tricyclic antidepressants, sodium oxybate, and selective serotonin reuptake inhibitor markets.
Q4. Who are the key narcolepsy drug market companies?
Answer: Some of the key narcolepsy drug companies are as follows:
• Arena Pharmaceuticals
• Bioprojet Company
• Graymark Healthcare
• Hikma Pharmaceuticals
• Jazz Pharmaceuticals
• Ligand Pharmaceuticals Incorporated
• Shionogi
Q5. Which narcolepsy drug market segment will be the largest in future?
Answer: Lucintel forecasts that daytime extreme sleepiness will remain the larger segment over the forecast period due to development of drugs for treating narcolepsy.
Q6. In narcolepsy drug market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to growing prevalence of unhealthy lifestyles along with increase in R&D activities in the region.
Q.7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the narcolepsy drug market by disease type (daytime extreme sleepiness, cataplexia, and others), therapeutics type (central nervous system stimulants, tricyclic antidepressants, sodium oxybate, selective serotonin reuptake inhibitor, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Narcolepsy Drug Market, Narcolepsy Drug Market Size, Narcolepsy Drug Market Growth, Narcolepsy Drug Market Analysis, Narcolepsy Drug Market Report, Narcolepsy Drug Market Share, Narcolepsy Drug Market Trends, Narcolepsy Drug Market Forecast, Narcolepsy Drug Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.